Galectin Therapeutics (GALT): more upside on the horizon?

5:13 pm ET, 13 Jun 2018

Galectin Therapeutics (GALT) is up 23% post-market close today.  The investor sentiment on Stocktwits is 97%, and traders are wondering what's the forecast for this stock.  

GALT average analyst price target is $8.50, and the price target upside is 8.70% (type "GALT price target" and "GALT upside" on Finstead.com to get the latest views).

Despite the positive stock sentiment, short interest ratio is relatively high. 

S&P Captial deems that the stock in poor financial health.  Financial Health leverages fundamental data to assess the company’s debt and interest obligations (among other factors), and financial health in comparison to its peers.

Looking at the longer-term technical analysis, we concur that the near-term and long-term stock sentiment is also positive.  

 Galectin is a clinical-stage biopharmaceutical company, targeting therapies for fibrotic disease, skin disease, and cancer. 

The company's lead product candidate includes galectin-3 inhibitor (GR-MD-02) for the treatment of liver fibrosis and liver cirrhosis in non-alcoholic steatohepatitis patients, as well as for the treatment of cancer. 

Galectin Therapeutics was founded in 2000 and is based in Norcross, Georgia.

Disclaimer: The news article above expresses the author’s opinion about the topic of the article. We strongly advise you not to base your investment decisions just on this article alone. If you’d like to become a writer for Finny Bites, please send us an email at hi@askfinny.com.

Galectin Therapeutics Inc. (GALT) Stock Guide

Updated at: 8:00 am ET, 12 Jul 2020

Before we start: if you're looking for GALT stock price, you can quickly find it out by visiting Finny and typing "GALT quote". If you're looking for a quick scoop on GALT stock (chart, price target, market cap, news and buy or sell analysis), go to Finny and look for "GALT". You'll get all this info in one place. Or you can just type "GALT news" to get the latest stock news.

Looking to buy or sell Galectin Therapeutics Inc. (GALT)? Interested in getting the full scoop on GALT, including earnings and dividends, stock forecast, buy or sell analysis and key stats? If so, you came to the right place.

In this GALT stock guide, we'll address key questions about GALT, above and beyond what you can find on Yahoo Finance, Zacks, MarketWatch or Morningstar.

Here is what you'll be able to find in this guide:

Earnings and Dividends: earnings, earnings date, dividend rate and dividend yield;
Analyst Predictions: stock forecast and analyst ratings;
Analysis: Finny Score and buy or sell analysis;
Key Stats: revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio, industry, sector, and number of employees.

And here is the list of questions we'll answer:
1. What are GALT earnings?
2. When is GALT earnings date?
3. What is GALT stock forecast (i.e., prediction)?
4. GALT buy or sell? What is GALT Finny Score?
5. What are the reasons to buy GALT? Why should I buy GALT stock?
6. What are the reasons to sell GALT? Why should I sell GALT stock?
7. What are GALT key stats: revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio industry, sector, and number of employees?

So let's start. Scroll down to the question that interests you the most.

Earnings and Dividends

1. What are GALT earnings?

GALT trailing 12-month earnings per share (EPS) is -$0.39.

2. When is GALT earnings date?

GALT earnings date is August 07, 2020.

Analyst Predictions

3. What is GALT stock forecast (i.e., prediction)?

Based on GALT analyst price targets, GALT stock forecast is $6.50 (for a year from now). That means the average analyst price target for GALT stock is $6.50. The prediction is based on 3 analyst estimates.

The low price target for GALT is $4.00, while the high price target is $9.00.

GALT analyst rating is Buy.

Analysis

4. GALT buy or sell? What is GALT Finny Score?

#{finnyScore:60}Our quantitative analysis shows 3 reasons to buy and 2 reasons to sell GALT, resulting in Finny Score of 60.

5. What are the reasons to buy GALT? Why should I buy GALT stock?

Here are the reasons to buy GALT stock:

6. What are the reasons to sell GALT? Why should I sell GALT stock?

Let's look at the reasons to sell GALT stock (i.e., the bear case):

  • GALT short share of float is 18.34%. The stock is much more frequently shorted than the average industry, sector or S&P 500 stock. See GALT short share of float chart.
  • GALT short interest (days to cover the shorts) ratio is 17.28. The stock garners more short interest than the average industry, sector or S&P 500 stock. See GALT short interest ratio chart.

Key Stats

7. What are GALT key stats : revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio industry, sector, and number of employees?

Let's look at the key statistics for GALT:

Metrics GALT
Price $2.59
Average Price Target / Upside $6.50 / 150.97%
Average Analyst Rating Buy
Forward Dividend Yield 0.00%
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Number of Employees 6
Market Cap $148.85M
Forward P/E Ratio -5.22
Price/Book Ratio N/A
Revenue (TTM) N/A
YoY Quarterly Revenue Growth N/A
Profit Margin 0.00%

If you liked this analysis, check out Stock Guides for other stocks.

Disclaimer: The news article above expresses the author’s opinion about the topic of the article. We strongly advise you not to base your investment decisions just on this article alone. If you’d like to become a writer for Finny Bites, please send us an email at hi@askfinny.com.

Use Finny to ask any finance or investment question. Big or small. Personal or general.
Follow Us